ReviewCureus2025
Harnessing Artificial Intelligence for Precision Cardiovascular Medicine.
Review in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Artificial intelligence (AI) has revolutionized cardiology diagnostic capabilities by improving precision, effectiveness, and prompt identification of various cardiac diseases. AI subfields include machine learning, deep learning, and cognitive computing. Machine learning can be supervised, unsupervised, or reinforcement learning. Support vector machines (SVM), deep learning, and artificial neural networks (ANN) are commonly used in the medical field for handling large and complex data. ANNs perform better than SVMs in evaluating electrocardiogram (ECG) data, while SVMs are used for disease stratification. AI-driven diagnostic tools have transformed the interpretation of ECGs, echocardiograms, cardiac imaging, and other diagnostic modalities, leading to better patient outcomes and more accurate clinical decision-making. AI has shown promise in identifying and describing coronary artery disease, with machine learning models training on cardiac CT images. Non-invasive AI tools, like HeartFlow, help patients with cardiac autonomic dysfunction (CAD) with treatment planning and decision-making. AI systems often require access to sensitive patient data, raising concerns about privacy, data security, and consent. Additionally, using patient data without clear ethical oversight may erode public trust. Transparency in how AI tools use and protect data is essential to maintain ethical standards in cardiovascular medicine.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.